The main approach to managing NASH is weight loss, usually achieved via diet and exercise. Although no standard medications or treatments are approved for NASH, medications are prescribed to manage overall cardiometabolic risk from other comorbid conditions such as diabetes, hyperlipidemia or cardiovascular disease. In severe cases, liver transplantation may be needed if NASH has progressed to end stage liver disease.[1][2]
Hepatitis A and Hepatitis B vaccinations in unvaccinated individuals would reduce the risk of additional liver damage.